|
gptkbp:instanceOf
|
gptkb:antibiotic
fluoroquinolone
|
|
gptkbp:administeredBy
|
gptkb:dog
gptkb:livestock
cats
pigs
poultry
|
|
gptkbp:affiliatedWith
|
quinolone antibiotics
|
|
gptkbp:ATCCode
|
gptkb:QJ01MA90
|
|
gptkbp:CASNumber
|
gptkb:93106-60-6
|
|
gptkbp:chemicalFormula
|
gptkb:C19H22FN3O3
|
|
gptkbp:compatibleWith
|
human use
|
|
gptkbp:contraindication
|
pregnant animals
growing dogs
|
|
gptkbp:discoveredBy
|
gptkb:Bayer_AG
|
|
gptkbp:eliminationHalfLife
|
4-5 hours (dogs)
6 hours (cats)
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
enrofloxacin
|
|
gptkbp:introducedIn
|
1987
|
|
gptkbp:legalStatus
|
veterinary prescription only
|
|
gptkbp:marketedAs
|
gptkb:Baytril
|
|
gptkbp:mechanismOfAction
|
inhibits DNA gyrase
inhibits topoisomerase IV
|
|
gptkbp:metabolism
|
ciprofloxacin
|
|
gptkbp:prohibits
|
poultry in the United States
|
|
gptkbp:regulates
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:riskFactor
|
gptkb:antibiotic
|
|
gptkbp:routeOfAdministration
|
oral
injectable
|
|
gptkbp:sideEffect
|
gastrointestinal upset
cartilage damage in young animals
|
|
gptkbp:solubility
|
slightly soluble in water
|
|
gptkbp:synonym
|
gptkb:Baytril
|
|
gptkbp:usedFor
|
bacterial infections in animals
|
|
gptkbp:bfsParent
|
gptkb:Bayer_Baytril_(veterinary_product)
gptkb:Baytril
|
|
gptkbp:bfsLayer
|
6
|